Diphenhydramine Oral Liquid
Product Images NDC 53807-204

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Diphenhydramine Oral Liquid (NDC 53807-204). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rij Pharmaceutical Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Principal Display Panel (Allergy 01)

Principal Display Panel (Allergy 01)
This is a drug facts label for an oral liquid allergy medicine containing 12.5mg of Diphenhydramine hydrochloride per teaspoonful. It is indicated to temporarily relieve symptoms of upper respiratory allergies such as runny nose, sneezing, and itchy, watery eyes. It is also indicated for temporary relief of symptoms associated with the common cold. The label warns against use with other products containing diphenhydramine, especially those used on the skin, and advises consultation with a doctor before use for people with certain conditions. The label also warns against using alcohol or medications that cause drowsiness while taking this medicine, and notes the possibility of marked drowsiness and excitability, especially in children. Directions are provided for use of the medication for adults and children over 12 years of age, for children between 2 and 12 years of age, and recommends consulting a doctor for children under 6 years. The label also provides information on storage requirements, inactive ingredients, and tamper-resistant packaging.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.